COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.
In what was very big news for global health, the World Health Organisation (WHO) has recommended a new vaccine for the prevention of malaria in children, called R21/Matrix-M.
An 8 cm roundworm that would usually be more at home in a carpet python was pulled live from a woman’s brain, in a case that had baffled a team of specialists for more than a year.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.